☆ 4.7 Letter

Response to Inhaled Zanamivir versus Oral Oseltamivir to Prevent Influenza-related Hospitalization or Death: A Nationwide Population-based Quasi-experimental Study

CLINICAL INFECTIOUS DISEASES (2022)

Related references

Note: Only part of the references are listed.

Article Immunology

Inhaled Zanamivir vs Oral Oseltamivir to Prevent Influenza-related Hospitalization or Death: A Nationwide Population-based Quasi-experimental Study

Chia-Ping Su et al.

Summary: The study shows that inhaled zanamivir is as effective as oral oseltamivir in preventing influenza-related hospitalization or death for outpatients.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Article Critical Care Medicine

Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting (32-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting (32-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study

Meng-Ting Wang et al.

Summary: In this study, the comparative effectiveness and safety of LABA/LAMA and LABA/ICS FDCs in COPD patients were investigated using Taiwanese nationwide health care claims. Indacaterol plus glycopyrronium (IND/GLY) and vilanterol plus umeclidinium (VI/UMEC) were found to be associated with lower exacerbation rates and pneumonia risks compared to salmeterol plus fluticasone propionate (SAL/FP). However, no significant differences were observed between LABA/LAMA FDCs.

CHEST (2021)

Add to Collection

Article Infectious Diseases

Cigarette smoking as a risk factor for influenza-associated mortality: evidence from an elderly cohort

Chit M. Wong et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)

Add to Collection

Article Immunology

Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort Study

Jeffrey C. Kwong et al.

CLINICAL INFECTIOUS DISEASES (2011)

Add to Collection

Article Medicine, General & Internal

Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza

Alexia Campbell et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)

Add to Collection

Response to Inhaled Zanamivir versus Oral Oseltamivir to Prevent Influenza-related Hospitalization or Death: A Nationwide Population-based Quasi-experimental Study

Related references

Inhaled Zanamivir vs Oral Oseltamivir to Prevent Influenza-related Hospitalization or Death: A Nationwide Population-based Quasi-experimental Study

Cigarette smoking as a risk factor for influenza-associated mortality: evidence from an elderly cohort

Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort Study

Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza

Export Citation

Share Paper